Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 22.54% vs -2.30% in Sep 2024
Standalone Net Profit
Growth in half year ended Sep 2025 is -35.19% vs -4.06% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is -19.21% vs -14.06% in Sep 2024
Interest
Growth in half year ended Sep 2025 is -6.45% vs 181.82% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Sep 2024
Compare Half Yearly Results Of Anuh Pharma With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
372.36
136.06
236.30
173.67%
Other Operating Income
0.00
0.00
0.00
Total Operating income
372.36
136.06
236.30
173.67%
Raw Material Cost
255.42
86.11
169.31
196.62%
Purchase of Finished goods
44.89
0.00
44.89
(Increase) / Decrease In Stocks
-3.15
0.04
-3.19
-7,975.00%
Employee Cost
13.04
12.47
0.57
4.57%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
39.99
19.86
20.13
101.36%
Total Expenditure (Excl Depreciation)
350.19
118.48
231.71
195.57%
Operating Profit (PBDIT) excl Other Income
22.17
17.58
4.59
26.11%
Other Income
4.37
5.83
-1.46
-25.04%
Operating Profit (PBDIT)
26.54
23.41
3.13
13.37%
Interest
0.29
2.37
-2.08
-87.76%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
26.25
21.04
5.21
24.76%
Depreciation
5.38
4.22
1.16
27.49%
Profit Before Tax
20.87
16.82
4.05
24.08%
Tax
4.96
4.09
0.87
21.27%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
15.91
12.73
3.18
24.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
15.91
12.73
3.18
24.98%
Equity Capital
50.11
6.89
43.22
627.29%
Face Value
5.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
1.59
18.48
-16.89
-91.40%
Diluted Earnings per share
1.59
18.47
-16.88
-91.39%
Operating Profit Margin (Excl OI)
5.95%
12.92%
0.00
-6.97%
Gross Profit Margin
7.05%
15.46%
0.00
-8.41%
PAT Margin
4.27%
9.36%
0.00
-5.09%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 372.36 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 22.54% vs -2.30% in Sep 2024
Half Yearly - Standalone Net Profit
Standalone Net Profit 15.91 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -35.19% vs -4.06% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.17 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -19.21% vs -14.06% in Sep 2024
Half Yearly - Interest
Interest 0.29 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -6.45% vs 181.82% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.95%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Sep 2024






